【Biopharmaceutical company Eyenovia launches HYPE Treasury Reserve Strategy, will invest $50 million】The clinical-stage ophthalmic biopharmaceutical company Eyenovia announced that it will invest $50 million to launch the Hyperliquid (HYPE) Treasury Reserve Strategy.